Epilepsy, Cognitive disorders, Affective disorders, Cognitive online training


Background. The study of features of comorbid pathology in patients with epilepsy is of particular interest due to the high prevalence of this pathology and a significant impact on the quality of life of patients and their social adaptation.

Aim. The aim of the research was to detect versatile cognitive impairments and affective disorders in epilepsy, and to study the results of cognitive training and psychoeducation.

Materials and methods. The theoretical analysis of modern scientific researches in the field of cognitive and affective impairments during epilepsy was carried out. We studied the features of clinical and psychopathological manifestations in patients, suffering from epilepsy. The study covered 146patients (85 men and 61 women) who were in inpatient care. The following psychodiagnostic techniques were used: the MOCA test,  the Toronto Cognitive Assessment (TorCA), the MiniMult test, the Münsterberg test, the quality of life scale, the Hamilton scale of depression and anxiety.

Results. This publication offers the results of a study of cognitive and affective disorders the quality of life in patients who suffer from epilepsy and the results of online cognitive training and psychoeducation. We found cognitive decline in 88% of patients with epilepsy and improvement of cognitive functions by methods of non-pharmacological correction.

Conclusions. Affective and cognitive disorders significantly affects the quality of life of patients, their ability to work and socialization. The conducted research showed that compared to the control group of healthy persons, patients with epilepsy showed improvement in their cognitive decline, anxiety and depressive disorders. Cognitive online training appeared to be effective for the patients with epilepsy.


Sen, A., Capelli, V., & Husain, M. (2018). Cognition and dementia in older patients with epilepsy. Brain, 141(6), 1592–1608. doi: 10.1093/brain/awy022

Helmstaedter, С. (2013). The impact of epilepsy cognitive function. J Neurol Neurosurg Psychiatry, 84, 5-15. doi: 10.1136/jnnp-2013-306103.14

Martsenkovskiy I. A., & Martsenkovskaya, I. I. (2015). Rasstroystva psikhiki i povedeniya pri epilepsiyakh: klinicheskaya tipologiya i terapevticheskie strategii [Mental and behavioral disorders in epilepsy: clinical typology and therapeutic strategies]. NeuroNEWS, 8, 21-33.

Gaitatzis, A., Trimble, M. R., & Sander, J. W. (2004). The psychiatric comorbidity of epilepsy. Acta Neurol Scand, 110(4), 207-220. doi: 10.1111/j.1600-0404.2004.00324.x

Gandy, M., Karin, E., Fogliati, V. J., McDonald, S., Titov, N., & Dear, B. F. (2016). A Feasibility Trial of an Internet-Delivered and Transdiagnostic Cognitive Behavioral Therapy Treatment Program for Anxiety, Depression, and Disability Among Adults With Epilepsy. Epilepsia, 57(11), 1887–1896. doi: 10.1111/epi.13569

Mula, M., & Trimble, M. R. (2009). Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs, 23(2), 121–137. doi: 10.2165/00023210-200923020-00003

Dodrill, C. В. (1986). Correlates of generalized tonic–clonic seizures with intellectual, neuropsychological, emotional and social function in patients with epilepsy. Epilepsia, 27(4), 399-411. doi: 10.1111/j.1528-1157.1986.tb03559.x

Aldenkamp, A. P., & Bodde, N. (2005). Behaviour, cognition and epilepsy. Acta Neurol Scand Suppl, 112(s182), 19-25. doi: 10.1111/j.1600-0404.2005.00523.x

Millan, M. J., Agid, Y., Brune, M, Bullmore, E. T., Carter, C. S., Clayton, N. S., … & Young L. J. (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov, 11(2)2, 141-168. doi: 10.1038/nrd3628

Kanner, A. M., Wuu, J., Faught, E., Tatum, W. O. 4th, Fix, A., & French, J. A. (2003). A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav, 4(5), 548–552. doi: 10.1016/j.yebeh.2003.07.007

Unterberger, I., Zamarian, L., Prieschl, M., Bergmann, M., Walser, G., Luef, G., … & Delazer, M. (2018). Risky Decision Making in Juvenile Myoclonic Epilepsy. Front Neurol, 9, 195. doi: 10.3389/fneur.2018.00195

Osler, M., Mortensen, E. L., Christensen, K., & Christensen, G. T. (2018). A bidirectional association between cognitive ability in young adulthood and epilepsy: a population-based cohort study. Int J Epidemiol, 47(4), 1151-1158. doi: 10.1093/ije/dyy018

Strelnikova, I.N., & Polyakova, A.V. (2012). Struktura depressivnykh rasstroystv u bol'nykh epilepsiey [The structure of depressive disorders in patients with epilepsy]. Ukrajnskij visnyk psyhonevrologij, 20(3), 226.

Holmes, G. L. (2015). Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord, 17(2), 101-116. doi: 10.1684/epd.2015.0739

Wilson, R. S., Scherr, P. A., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007). Relation of cognitive activity to risk of developing Alzheimer disease. Neurology, 69(20), 1911–1920. doi: 10.1212/01.wnl.0000271087.67782.cb

Kolb, B., & Gibb, R. (2008). Principles of neuroplasticity and behavior. In: D. Stuss, G. Winocur, I. Robertson. Cognitive neurorehabilitation: Evidence and Application. Cambridge University Press, 6–21. doi: 10.1017/CBO9781316529898.003

Naumenkо, А. А., Gromova, D. О., & Preobrazhenkaya, I. S. (2017). Kognitivnyy trening i reabilitatsiya patsientov s kognitivnymi narusheniyami [Cognitive Training and Rehabilitation of Patients with Cognitive Impairments]. Doctor Ru, 11, 31-38.

Rodakowski, J., Saghafi, E., Butters, M. A., & Skidmore, E. R. (2015). Non­pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review. Mol. Aspects Med, 43-44, 38-53. doi: 10.1016/j.mam.2015.06.003.

Matsuoka, H., Nakamura, M., Ohno, T., Shimabukuro, J., Suzuki, T., Numachi, Y., & Awata, S. (2005). The role of cognitive-motor function in precipitation and inhibition of epileptic seizures. Epilepsia, 46(Suppl 1), 17-20. doi: 10.1111/j.0013-9580.2005.461006.x

Pakpour, A. H., Gholami, M., Esmaeili, R., Naghibi, S. A., Updegraff, J. A., Molloy, G. J., & Dombrowski, S. U. (2015). A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy Behav, 52(Pt A), 133-142. doi: 10.1016/j.yebeh.2015.08.036.

Tan, S. Y., & Bruni, J. (1986). Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia, 27(3), 225-233. doi: 10.1111/j.1528-1157.1986.tb03533.x

Carson, N., Leach, L., & Murphy, K. J. (2018). A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry, 33(2), 379-388. doi: 10.1002/gps.4756.

Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, & Kędziora-Kornatowska K. (2016). Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol, 50(5), 1039-1052. doi: 10.12740/PP/45368.

Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., … & Chertkow H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4), 695-699. doi: 10.1111/j.1532-5415.2005.53221.x

Poythress, N. G., & Blaney, P. H. (1978). The validity of MMPI interpretations based on the Minimult and the FAM. J Pers Assess, 42(2), 143-147. doi: 10.1207/s15327752jpa4202_5

Obeid, S., Hallit, C. E., Haddad, C., Hany, Z., & Hallit, S. (2018). Validation of the Hamilton Depression Rating Scale (HDRS) and sociodemographic factors associated with Lebanese depressed patients. Encephale, 44(5), 397-402. doi: 10.1016/j.encep.2017.10.010

Williams, J. B. (1988). A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry, 45(8), 742-747. doi: 10.1001/archpsyc.1988.01800320058007

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.